Arrowstreet Capital Limited Partnership Grows Holdings in The Cooper Companies, Inc. $COO

Arrowstreet Capital Limited Partnership grew its position in The Cooper Companies, Inc. (NASDAQ:COO) by 0.8% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,126,300 shares of the medical device company’s stock after acquiring an additional 17,602 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in Cooper Companies were worth $152,030,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the company. Root Financial Partners LLC grew its position in shares of Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 162 shares during the period. SJS Investment Consulting Inc. lifted its position in shares of Cooper Companies by 107.5% during the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after buying an additional 187 shares in the last quarter. Cromwell Holdings LLC raised its position in Cooper Companies by 128.8% during the fourth quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock worth $40,000 after acquiring an additional 273 shares during the period. CYBER HORNET ETFs LLC acquired a new position in shares of Cooper Companies during the 2nd quarter worth about $36,000. Finally, Physician Wealth Advisors Inc. lifted its stake in Cooper Companies by 4,276.9% in the 4th quarter. Physician Wealth Advisors Inc. now owns 569 shares of the medical device company’s stock valued at $47,000 after buying an additional 556 shares in the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on COO shares. Piper Sandler set a $86.00 price objective on Cooper Companies and gave the company an “overweight” rating in a research note on Monday, June 1st. JPMorgan Chase & Co. dropped their target price on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a report on Friday, June 5th. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Sunday, June 21st. The Goldman Sachs Group set a $61.00 price target on shares of Cooper Companies in a research note on Wednesday, May 27th. Finally, Mizuho set a $85.00 price target on shares of Cooper Companies and gave the stock an “outperform” rating in a research report on Thursday, June 4th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $81.85.

Cooper Companies Trading Up 0.1%

COO opened at $70.31 on Friday. The stock has a market capitalization of $13.71 billion, a PE ratio of 59.58, a P/E/G ratio of 1.84 and a beta of 0.84. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The business’s 50 day moving average price is $67.34 and its 200 day moving average price is $72.19.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, equities research analysts expect that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.